Table 2 Baseline Characteristics of trial participants
Characteristics | Control (n=12,132) | Intervention (n=12,484) |
|---|---|---|
Median age (25th, 75th percentile) | 55 (37–69) | 59 (41–72) |
Age category, % | ||
 16 to 29 years | 1734 (14%) | 1599 (13%) |
 30 to 40 years | 1768 (15%) | 1488 (12%) |
 41 to 65 years | 4775 (39%) | 4647 (37%) |
 66 to 80 years | 2774 (23%) | 3223 (26%) |
 80+ years | 1081 (9%) | 1527 (12%) |
Female, % | 7696 (63%) | 7976 (64%) |
Rural, % | 1052 (9%) | 2027 (16%) |
Neighbourhood income quintilea, % | ||
 1 (lowest quintile) | 2365 (20%) | 1789 (14%) |
 2 | 2349 (19%) | 2119 (17%) |
 3 | 2174 (18%) | 2317 (19%) |
 4 | 2456 (20%) | 3143 (25%) |
 5 (highest quintile) | 2743 (23%) | 3077 (25%) |
Comorbid conditions, % | ||
 Diabetes | 2084 (17%) | 2071 (17%) |
 Cancer | 3119 (26%) | 3436 (28%) |
 Congestive heart failure | 670 (6%) | 834 (7%) |
 Chronic kidney disease | 249 (2%) | 288 (2%) |
 Chronic liver disease | 528 (4%) | 493 (4%) |
 Chronic lung disease | 2594 (21%) | 2540 (20%) |
 Median family pPhysician visits in the past year, #, (Q1–Q3) | 5 (2–9) | 5 (3–9) |